• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Omalizumab in treatment-resistant chronic spontaneous urticaria.奥马珠单抗治疗难治性慢性自发性荨麻疹
Indian J Dermatol. 2011 Jul;56(4):444. doi: 10.4103/0019-5154.84737.
2
Efficacy of Omalizumab in Patients with Chronic Spontaneous Urticaria and Its Association with Serum IgE Levels and Eosinophil Count.奥马珠单抗治疗慢性自发性荨麻疹的疗效及其与血清IgE水平和嗜酸性粒细胞计数的关系。
Acta Dermatovenerol Croat. 2019 Jun;27(2):101-106.
3
Retreatment with omalizumab results in rapid remission in chronic spontaneous and inducible urticaria.奥马珠单抗再治疗可迅速缓解慢性自发性和诱导性荨麻疹。
JAMA Dermatol. 2014 Mar;150(3):288-90. doi: 10.1001/jamadermatol.2013.8705.
4
Effect of omalizumab on angioedema in H1 -antihistamine-resistant chronic spontaneous urticaria patients: results from X-ACT, a randomized controlled trial.奥马珠单抗对 H1 抗组胺药耐药性慢性自发性荨麻疹患者血管性水肿的影响：X-ACT 随机对照试验的结果。
Allergy. 2016 Aug;71(8):1135-44. doi: 10.1111/all.12870. Epub 2016 Mar 31.
5
Omalizumab in chronic urticaria.奥马珠单抗治疗慢性荨麻疹。
Curr Opin Allergy Clin Immunol. 2012 Aug;12(4):406-11. doi: 10.1097/ACI.0b013e328355365a.
6
Efficacy of omalizumab treatment for pediatric chronic spontaneous urticaria: A multi-center retrospective case series.奥马珠单抗治疗儿童慢性自发性荨麻疹的疗效：一项多中心回顾性病例系列研究。
Pediatr Dermatol. 2020 Nov;37(6):1051-1054. doi: 10.1111/pde.14360. Epub 2020 Sep 19.
7
Current challenges and controversies in the management of chronic spontaneous urticaria.慢性自发性荨麻疹管理中的当前挑战与争议
Expert Rev Clin Immunol. 2015;11(10):1073-82. doi: 10.1586/1744666X.2015.1069708. Epub 2015 Jul 15.
8
Algorithm for Treatment of Chronic Spontaneous Urticaria with Omalizumab.奥马珠单抗治疗慢性自发性荨麻疹的算法
Actas Dermosifiliogr (Engl Ed). 2018 Nov;109(9):771-776. doi: 10.1016/j.ad.2018.07.005. Epub 2018 Aug 11.
9
Long-term efficacy of omalizumab in seven patients with treatment-resistant chronic spontaneous urticaria.奥马珠单抗治疗7例难治性慢性自发性荨麻疹的长期疗效
Allergol Immunopathol (Madr). 2015 Mar-Apr;43(2):168-73. doi: 10.1016/j.aller.2013.11.007. Epub 2014 Apr 14.
10
Effects of omalizumab on basophils: Potential biomarkers in asthma and chronic spontaneous urticaria.奥马珠单抗对嗜碱性粒细胞的影响：哮喘和慢性自发性荨麻疹的潜在生物标志物。
Cell Immunol. 2020 Dec;358:104215. doi: 10.1016/j.cellimm.2020.104215. Epub 2020 Sep 12.

引用本文的文献

1
Prevalence, Clinical Manifestations, Treatment, and Clinical Course of Chronic Urticaria in Elderly: A Systematic Review.老年人慢性荨麻疹的患病率、临床表现、治疗及临床病程：一项系统评价
J Asthma Allergy. 2022 Oct 20;15:1455-1490. doi: 10.2147/JAA.S379912. eCollection 2022.
2
Benefits and Harms of Omalizumab Treatment in Adolescent and Adult Patients With Chronic Idiopathic (Spontaneous) Urticaria: A Meta-analysis of "Real-world" Evidence.奥马珠单抗治疗青少年和成人慢性特发性（自发性）荨麻疹患者的获益和危害：“真实世界”证据的荟萃分析。
JAMA Dermatol. 2019 Jan 1;155(1):29-38. doi: 10.1001/jamadermatol.2018.3447.
3
Omalizumab for Management of Refractory Urticaria: Experience of a Tertiary Care Centre in Eastern India.奥马珠单抗治疗难治性荨麻疹：印度东部一家三级医疗中心的经验
Indian J Dermatol. 2018 Jan-Feb;63(1):66-69. doi: 10.4103/ijd.IJD_342_16.
4
Consensus Statement for the Diagnosis and Treatment of Urticaria: A 2017 Update.《荨麻疹诊断和治疗的共识声明：2017年更新版》
Indian J Dermatol. 2018 Jan-Feb;63(1):2-15. doi: 10.4103/ijd.IJD_308_17.
5
Treatment of Chronic Spontaneous Urticaria with a Single Dose of Omalizumab: A Study of Four Cases.单剂量奥马珠单抗治疗慢性自发性荨麻疹：4例病例研究
Indian J Dermatol. 2016 Jul-Aug;61(4):467. doi: 10.4103/0019-5154.185745.
6
Position statement for the use of omalizumab in the management of chronic spontaneous urticaria in Indian patients.关于奥马珠单抗用于印度患者慢性自发性荨麻疹管理的立场声明。
Indian Dermatol Online J. 2016 Jan-Feb;7(1):6-11. doi: 10.4103/2229-5178.174314.
7
Omalizumab-A Review.奥马珠单抗综述
Indian J Dermatol. 2015 Jul-Aug;60(4):381-4. doi: 10.4103/0019-5154.160490.
8
Treatment of Refractory Chronic Urticaria.难治性慢性荨麻疹的治疗
Indian J Dermatol. 2015 May-Jun;60(3):230-7. doi: 10.4103/0019-5154.156325.
9
Omalizumab for chronic urticaria: a case series and overview of the literature.奥马珠单抗治疗慢性荨麻疹：病例系列及文献综述
Case Rep Dermatol. 2012 Jan;4(1):19-26. doi: 10.1159/000336205. Epub 2012 Jan 30.

本文引用的文献

1
Omalizumab--an effective and safe treatment of therapy-resistant chronic spontaneous urticaria.奥马珠单抗——治疗难治性慢性自发性荨麻疹的一种有效且安全的疗法。
Allergy. 2011 Feb;66(2):303-5. doi: 10.1111/j.1398-9995.2010.02472.x. Epub 2010 Sep 7.
2
Unmet clinical needs in chronic spontaneous urticaria. A GA²LEN task force report.慢性自发性荨麻疹未满足的临床需求。GA²LEN 工作组报告。
Allergy. 2011 Mar;66(3):317-30. doi: 10.1111/j.1398-9995.2010.02496.x. Epub 2010 Nov 17.
3
Anti-immunoglobulin E treatment of patients with recalcitrant physical urticaria.抗免疫球蛋白 E 治疗难治性物理性荨麻疹患者。
Int Arch Allergy Immunol. 2011;154(2):177-80. doi: 10.1159/000320233. Epub 2010 Aug 24.
4
EAACI/GA(2)LEN/EDF/WAO guideline: management of urticaria.EAACI/GA(2)LEN/EDF/WAO 指南：荨麻疹的管理。
Allergy. 2009 Oct;64(10):1427-1443. doi: 10.1111/j.1398-9995.2009.02178.x.
5
EAACI/GA(2)LEN/EDF/WAO guideline: definition, classification and diagnosis of urticaria.EAACI/GA(2)LEN/EDF/WAO 指南：荨麻疹的定义、分类和诊断。
Allergy. 2009 Oct;64(10):1417-1426. doi: 10.1111/j.1398-9995.2009.02179.x.
6
Treatment of chronic autoimmune urticaria with omalizumab.用奥马珠单抗治疗慢性自身免疫性荨麻疹。
J Allergy Clin Immunol. 2008 Sep;122(3):569-73. doi: 10.1016/j.jaci.2008.07.006.
7
Omalizumab in severe chronic urticaria.奥马珠单抗治疗重度慢性荨麻疹
Indian J Dermatol Venereol Leprol. 2008 Mar-Apr;74(2):157-8. doi: 10.4103/0378-6323.39708.

Omalizumab in treatment-resistant chronic spontaneous urticaria.

作者信息

Godse Kiran V

机构信息

Skin Department, Shree Skin Centre, 22, L market, Sector 8, Nerul, Navi Mumbai, India. E-mail:

出版信息

Indian J Dermatol. 2011 Jul;56(4):444. doi: 10.4103/0019-5154.84737.

DOI:10.4103/0019-5154.84737
PMID:21965862
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3179017/
Abstract
摘要